Postmastectomy locally recurrent breast cancer.
With the popularity of breast-conserving treatment plans, the natural history of "breast recurrence" in the ipsilateral breast must be distinguished from local recurrence following modified radical mastectomy. Hence, this study considers those patients who develop skin or chest wall recurrence after modified radical mastectomy, whether as a primary procedure or for patients with "breast recurrence" after partial mastectomy. The incidence of postmastectomy locally recurrent breast cancer following modified radical mastectomy (MRM) and adjuvant immunotherapy (IT) is compared to historical controls. The risk factors and treatment of local recurrence in this program as well as in a larger group of patients who recurred after modified radical mastectomy are reported.
Humphrey
L J
LJ
Department of Surgery, Oral Roberts School of Medicine, Tulsa, Oklahoma.
Moore
D L
DL
Lytle
G H
GH
D001943:Breast Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007167:Immunotherapy; D015994:Incidence; D008207:Lymphatic Metastasis; D015411:Mastectomy, Modified Radical; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology* / Q000628:therapy; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate